Probucol: Hope wonder drug can treat both Parkinson's and Alzheimer's diseases in new Perth trial
A new clinical trial to treat Parkinson's disease will start in Perth next year using a drug currently under investigation as a ground-breaking treatment for Alzheimer's disease.
Probucol, a drug originally used in the 1980s to treat cardiovascular disease and lower cholesterol, has since been found to have potent anti-inflammatory and anti-oxidant effects on the brain.
The Probucol in Alzheimer's disease study, which started in 2021 and has so far recruited around 100 people, has just received ethics approval to extend treatment access for participants for an additional two years.
Professor John Mamo, the trial's chief investigator, said results from the two-year double blind trial were not yet available, but the open label extension was an 'exciting opportunity' for those taking part.
'The scientific significance lies in combining data from both the PIA study and the open-label extension. We'll gain insight into the efficacy of four years of treatment and also understand the impact of delaying treatment by two years — as in the case of those originally randomised to placebo,' Professor Mamo said.
Professor Mamo, Head of Neurovascular and Metabolic Diseases at the Perron Institute and Curtin University, said Probucol has properties that are highly relevant across several neurodegenerative conditions and Parkinson's disease was the next target for investigation.
In the context of Alzheimer's, Professor Mamo and his research team discovered that amyloid, a key protein implicated in the disease, is secreted outside the brain as part of fat-carrying particles called lipoproteins.
They showed that when amyloid-rich lipoproteins are excessively abundant in the blood, they compromise the integrity of microscopic brain vessels, allowing amyloid to leak into the brain and trigger inflammation.
'We found that Probucol powerfully suppresses the synthesis and secretion of amyloid into the blood, preserving brain capillaries and preventing brain cell loss due to inflammation,' he said.
But Professor Mamo said that amyloid plaque build-up in the brain likely represents the end stage of this damaging process — suggesting it may be the metabolic process beforehand, not the plaque itself, that principally drives the disease.
Preclinical studies have shown that Probucol can profoundly preserve cognitive function in models of Alzheimer's.
He said new monoclonal antibody therapies available to treat Alzheimer's were highly effective at reducing plaque burden but only had modest effects on halting cognitive decline.
'It's still unclear whether plaques are more a consequence than a cause,' he said.
The Parkinson's trial will start in 2026 through the Perron Institute and Curtin University with Perth being the main research site.
Alzheimer's disease is the biggest killer of women in Australia, and the second biggest for men and women. Professor Mamo said women with the disease deteriorate at three times the rate of men.
Parkinson's disease is the fastest growing neurogenerative disease with 150,000 people living with it in Australia and 20 per cent of them are below retirement age.
The Probucol in Alzheimer's study is looking to recruit around 50 more people who can contact the PIA study team on piastudy@curtin.edu.au.
They do not need a doctor's referral or a diagnosis of Alzheimer's or dementia to be considered and can contact the PIA study team on
piastudy@curtin.edu.au
or 0
468 532 458
.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
West Australian
2 hours ago
- West Australian
Breast cancer survivors less likely to develop Alzheimer's in five years post-cancer survival
Survivors of breast cancer may be less likely to develop Alzheimer's disease in the years following treatment. Researchers from Seoul National University College of Medicine in South Korea made the discovery when investigating concerns around loss of brain function after cancer. They compared the data of 70,000 Korean breast cancer surgery patients with about 140,000 people of a similar demographic who did not have breast cancer, following up for an average of just over seven years. The researchers found survivors were almost 10 per cent less likely to develop the neurodegenerative disease during the study, particularly among survivors older than 65-years-old. But the reduced risk was only apparent for the first five years of survival. The most common form of dementia, Alzheimer's disease manifests as a gradual decline in memory, thinking, and reasoning skills. 'Concerns about chemobrain and the long-term adverse effects of breast cancer treatment on cognition are common, but our findings suggest that this treatment does not directly lead to AD (Alzheimer dementia),' the study said. 'Understanding the potential protective association of breast cancer on AD can enhance surveillance strategies for AD among these survivors.' The study, published in JAMA Network Open, also found radiation therapy was associated with a lower risk of Alzheimer's in breast cancer survivors compared to other therapies. It opens a new investigation pathway for researchers, who say it's possible certain cancer treatments could have an impact on Alzheimer's risk. The researchers recommended further studies with long-term observation periods be undertaken to examine the long-term associations between Alzheimer's risk and breast cancer survival.
Perth Now
2 days ago
- Perth Now
Busy social life during 50s can signify Alzheimer's disease
Old people socialising Credit: BANG - Entertainment News BANG - Entertainment News Bang Showbiz A busy social life in your 50s could be an indicator of Alzheimer's disease. A massive study of almost half a million Brits aged 40 and older found that people with a higher genetic risk for Alzheimer's tended to report two per cent more social activity and three per cent less isolation in their 50s. Dr. Ashwin Kotwal, lead researcher at the University of California, San Francisco (UCSF), said: "We don't know if they're chasing more chatter or if others are rallying around them. Their social lives may expand in these early stages." Traditional wisdom suggests friendships and family time protect brain health by boosting "cognitive reserve". But this study highlights a reversal to the trend and suggests that alarm bells should ring if a person's schedule becomes jam packed for no obvious reason.
The Advertiser
5 days ago
- The Advertiser
Running pioneer, Boston winner Nina Kuscsik dead at 86
Nina Kuscsik, who campaigned for women's inclusion in long-distance running and then won the Boston Marathon the first year that they were officially allowed to race, has died aged 86. A funeral home notice said Kuscsik died June 8 of respiratory failure after a long battle with Alzheimer's disease. "Nina was more than a pioneer, determined women's running advocate, and celebrated icon within the sport," the Boston Athletic Association said in a social media post. "To us, she was a friend who will always be remembered for her kindness, joyful laugh and smile. "Nina held the distinct honour of winning the 1972 Boston Marathon, and recognised the platform that came with that triumphant moment, inspiring thousands of women to reach their own goals and finish lines in the decades since." Kuscsik graduated from high school at 16, studied nursing for two years and received her licence at 18 after petitioning to change a New York law that required nurses to be 21. She won state championships in speed skating, roller skating and cycling – all in the same year -- before turning to running when her bicycle broke. She ran the Boston Marathon four times from 1968-71 — before women were officially welcomed, a period retroactively recognised as the Pioneer Era — and then won the first official women's race in 1972. She was also the first woman to enter the New York race, in 1970, and was one of the "Six who Sat" – six women who refused to start the '72 New York City Marathon for 10 minutes to protest an Amateur Athletic Union rule that the women's race had to be separate from the men's. She won that year and the next year as well. She later served on AAU and USA Track and Field committees drafting rules for women's running. In addition to the more than 80 marathons she ran over her lifetime, Kuscsik set the American record for the 50-mile run in 1977 and won the Empire State Building Run-Up three straight years from 1979–81. She was inducted into the Long Distance Running Hall of Fame in 1999. Nina Kuscsik, who campaigned for women's inclusion in long-distance running and then won the Boston Marathon the first year that they were officially allowed to race, has died aged 86. A funeral home notice said Kuscsik died June 8 of respiratory failure after a long battle with Alzheimer's disease. "Nina was more than a pioneer, determined women's running advocate, and celebrated icon within the sport," the Boston Athletic Association said in a social media post. "To us, she was a friend who will always be remembered for her kindness, joyful laugh and smile. "Nina held the distinct honour of winning the 1972 Boston Marathon, and recognised the platform that came with that triumphant moment, inspiring thousands of women to reach their own goals and finish lines in the decades since." Kuscsik graduated from high school at 16, studied nursing for two years and received her licence at 18 after petitioning to change a New York law that required nurses to be 21. She won state championships in speed skating, roller skating and cycling – all in the same year -- before turning to running when her bicycle broke. She ran the Boston Marathon four times from 1968-71 — before women were officially welcomed, a period retroactively recognised as the Pioneer Era — and then won the first official women's race in 1972. She was also the first woman to enter the New York race, in 1970, and was one of the "Six who Sat" – six women who refused to start the '72 New York City Marathon for 10 minutes to protest an Amateur Athletic Union rule that the women's race had to be separate from the men's. She won that year and the next year as well. She later served on AAU and USA Track and Field committees drafting rules for women's running. In addition to the more than 80 marathons she ran over her lifetime, Kuscsik set the American record for the 50-mile run in 1977 and won the Empire State Building Run-Up three straight years from 1979–81. She was inducted into the Long Distance Running Hall of Fame in 1999. Nina Kuscsik, who campaigned for women's inclusion in long-distance running and then won the Boston Marathon the first year that they were officially allowed to race, has died aged 86. A funeral home notice said Kuscsik died June 8 of respiratory failure after a long battle with Alzheimer's disease. "Nina was more than a pioneer, determined women's running advocate, and celebrated icon within the sport," the Boston Athletic Association said in a social media post. "To us, she was a friend who will always be remembered for her kindness, joyful laugh and smile. "Nina held the distinct honour of winning the 1972 Boston Marathon, and recognised the platform that came with that triumphant moment, inspiring thousands of women to reach their own goals and finish lines in the decades since." Kuscsik graduated from high school at 16, studied nursing for two years and received her licence at 18 after petitioning to change a New York law that required nurses to be 21. She won state championships in speed skating, roller skating and cycling – all in the same year -- before turning to running when her bicycle broke. She ran the Boston Marathon four times from 1968-71 — before women were officially welcomed, a period retroactively recognised as the Pioneer Era — and then won the first official women's race in 1972. She was also the first woman to enter the New York race, in 1970, and was one of the "Six who Sat" – six women who refused to start the '72 New York City Marathon for 10 minutes to protest an Amateur Athletic Union rule that the women's race had to be separate from the men's. She won that year and the next year as well. She later served on AAU and USA Track and Field committees drafting rules for women's running. In addition to the more than 80 marathons she ran over her lifetime, Kuscsik set the American record for the 50-mile run in 1977 and won the Empire State Building Run-Up three straight years from 1979–81. She was inducted into the Long Distance Running Hall of Fame in 1999. Nina Kuscsik, who campaigned for women's inclusion in long-distance running and then won the Boston Marathon the first year that they were officially allowed to race, has died aged 86. A funeral home notice said Kuscsik died June 8 of respiratory failure after a long battle with Alzheimer's disease. "Nina was more than a pioneer, determined women's running advocate, and celebrated icon within the sport," the Boston Athletic Association said in a social media post. "To us, she was a friend who will always be remembered for her kindness, joyful laugh and smile. "Nina held the distinct honour of winning the 1972 Boston Marathon, and recognised the platform that came with that triumphant moment, inspiring thousands of women to reach their own goals and finish lines in the decades since." Kuscsik graduated from high school at 16, studied nursing for two years and received her licence at 18 after petitioning to change a New York law that required nurses to be 21. She won state championships in speed skating, roller skating and cycling – all in the same year -- before turning to running when her bicycle broke. She ran the Boston Marathon four times from 1968-71 — before women were officially welcomed, a period retroactively recognised as the Pioneer Era — and then won the first official women's race in 1972. She was also the first woman to enter the New York race, in 1970, and was one of the "Six who Sat" – six women who refused to start the '72 New York City Marathon for 10 minutes to protest an Amateur Athletic Union rule that the women's race had to be separate from the men's. She won that year and the next year as well. She later served on AAU and USA Track and Field committees drafting rules for women's running. In addition to the more than 80 marathons she ran over her lifetime, Kuscsik set the American record for the 50-mile run in 1977 and won the Empire State Building Run-Up three straight years from 1979–81. She was inducted into the Long Distance Running Hall of Fame in 1999.
